Inhibition of PRMT5-mediated regulation of DKK1 sensitizes colorectal cancer cells to chemotherapy
Cellular Signalling · 2024
DOI: 10.1016/j.cellsig.2024.111166 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2024. Verfasst von Wafaa Abumustafa und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates; Research Institute of Medical and He…. Hauptthemen laut MEDLINE: Protein-Arginine N-Methyltransferases, Colorectal Neoplasms, Intercellular Signaling Peptides and Proteins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: King Hussein Cancer Foundation, University of Sharjah.
Themen: Onkologische Pflege
Abstract (Originalsprache)
The Dickkopf family proteins (DKKs) are strong Wnt signaling antagonists that play a significant role in colorectal cancer (CRC) development and progression. Recent work has shown that DKKs, mainly DKK1, are associated with the induction of chemoresistance in CRC and that DKK1 expression in cancer cells correlates with that of protein arginine N-methyltransferase 5 (PRMT5). This points to the presence of a regulatory loop between DKK1 and PRMT5. Herein, we addressed the question of whether PRMT5 contributes to DKK1 expression in CRC and hence CRC chemoresistance. Both in silico and in vitro approaches were used to explore the relationship between PRMT5 and different DKK members. Our data demonstrated that DKK1 expression is significantly upregulated in CRC clinical samples, KRAS-mutated CRC in particular and that the levels of DKK1 positively correlate with PRMT5 activation. Chromatin immunoprecipitation (ChIP) data indicated a possible epigenetic role of PRMT5 in regulating DKK1, possibly through the symmetric dimethylation of H3R8. Knockdown of DKK1 or treatment with the PRMT5 inhibitor CMP5 in combination with doxorubicin yielded a synergistic anti-tumor effect in KRAS mutant, but not KRAS wild-type, CRC cells. These findings suggest that PRMT5 regulates DKK1 expression in CRC and that inhibition of PRMT5 modulates DKK1 expression in such a way that reduces CRC cell growth.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Basic Medical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates; Research Institute of Medical and Health Sciences, and College of Medicine, University of Sharjah, Sharjah…
- First Medical Department, University Medical Centre Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.
- University Medical Centre of the Johannes Gutenberg, University Mainz, Mainz, Germany.
- Research Institute of Medical and Health Sciences, and College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.
- Research Institute of Medical and Health Sciences, and College of Medicine, University of Sharjah, Sharjah, United Arab Emirates; Department of Medical Laboratory Sciences, College of Health Sciences, University of Shar…
Förderung
- King Hussein Cancer Foundation
- University of Sharjah
Zitieren
APA
Abumustafa, W., Castven, D., Becker, D., Salih, S. S., Manzoor, S., Zamer, B. A., Talaat, I., Hamad, M., Marquardt, J. U., & Muhammad, J. S. (2024). Inhibition of PRMT5-mediated regulation of DKK1 sensitizes colorectal cancer cells to chemotherapy. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2024.111166
Vancouver
Abumustafa W, Castven D, Becker D, Salih SS, Manzoor S, Zamer BA, et al. Inhibition of PRMT5-mediated regulation of DKK1 sensitizes colorectal cancer cells to chemotherapy. Cellular Signalling. 2024. doi:10.1016/j.cellsig.2024.111166
BibTeX
@article{Abumustafa2024,
author = {Abumustafa, Wafaa and Castven, Darko and Becker, Diana and Salih, Shahenaz Shaban and Manzoor, Shaista and Zamer, Batoul Abi and Talaat, Iman and Hamad, Mawieh and Marquardt, Jens Uwe and Muhammad, Jibran Sualeh},
title = {Inhibition of PRMT5-mediated regulation of DKK1 sensitizes colorectal cancer cells to chemotherapy},
journal = {Cellular Signalling},
year = {2024},
doi = {10.1016/j.cellsig.2024.111166}
}
EUVIMED